The IncRNA in question is known as HOTAIR, where cancer-derived HOTAIRs differentiated B cells into a regulatory phenotype associated with programmed death ligand 1 (PD-L1), these PD-L1+ B cells then inhibit the cytotoxic activity of CD8 + T cells promoting an immunosuppressive TME (46). The gene discussed is CD8A; the disease is cancer.